The objectives of the exercise are:
- To develop a greater awareness of the subject of epidemic antimicrobial resistance threats;
- To identify gaps in current arrangements to detect, verify, ascertain the public health impact and assess risk associated with an unusual cluster of serious healthcare-associated infections caused by a difficult-to-treat, pandrug-resistant bacterial strain;
- To consider the cross-border implications of such an event and suggest strategies for mitigation;
- To consider how the healthcare and public health community can work more closely together at national and international level taking into account EU legislation, such as Decision 1082/2013/EU on serious cross-border threats to health, Directive 2011/24/EU on the application of patients’ rights in cross-border healthcare and any other EU legislation, as well as the European One-Health Action Plan on Antimicrobial Resistance;
- To consider the interaction and coordination between the EU healthcare and public health community with international partners and third countries in case of a crisis of international significance beyond the EU;
- To consider the role of International agencies, such as the World Health Organization (WHO) and the European Centre for Disease Prevention and Control (ECDC) in relation to its mandate regarding risk identification, risk assessment and surveillance.
Last modified: Thursday, 27 June 2019, 6:12 PM